{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:55:18Z","timestamp":1769860518810,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM120350"],"award-info":[{"award-number":["R01GM120350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5R01GM111639"],"award-info":[{"award-number":["5R01GM111639"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5R01GM115844"],"award-info":[{"award-number":["5R01GM115844"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"IU School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bmcl.2019.02.028","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T13:21:52Z","timestamp":1551360112000},"page":"1106-1112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["HSP60\/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules"],"prefix":"10.1016","volume":"29","author":[{"given":"Mckayla","family":"Stevens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanofar","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilshad","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Washburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhi","family":"Chitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Sivinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangshin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quyen Q.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.02.028_b0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2019.02.028_b0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.bmcl.2019.02.028_b0015","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1128\/JB.00736-08","article-title":"Protein aggregates: an aging factor involved in cell death","volume":"190","author":"Maisonneuve","year":"2008","journal-title":"J Bacter"},{"key":"10.1016\/j.bmcl.2019.02.028_b0020","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1073\/pnas.170280697","article-title":"Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease","volume":"97","author":"Carmichael","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2019.02.028_b0025","doi-asserted-by":"crossref","first-page":"12263","DOI":"10.1074\/jbc.M109633200","article-title":"Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy","volume":"277","author":"Bao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.02.028_b0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jsb.2003.11.006","article-title":"Chaperone networks in bacteria: analysis of protein homeostasis in minimal cells","volume":"146","author":"Wong","year":"2004","journal-title":"J Struct Biol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004366","article-title":"Integrating protein homeostasis strategies in prokaryotes","volume":"3","author":"Mogk","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/371578a0","article-title":"The crystal structure of the bacterial chaperonin GroEL at 2.8 A","volume":"371","author":"Braig","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2019.02.028_b0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.biochem.67.1.581","article-title":"Structure and function in GroEL-mediated protein folding","volume":"67","author":"Sigler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bmcl.2019.02.028_b0050","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/cr040435v","article-title":"GroEL-GroES-mediated protein folding","volume":"106","author":"Horwich","year":"2006","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2019.02.028_b0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/371614a0","article-title":"Residues in chaperonin GroEL required for polypeptide binding and release","volume":"371","author":"Fenton","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2019.02.028_b0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/pro.5560060401","article-title":"GroEL-mediated protein folding","volume":"6","author":"Fenton","year":"1997","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmcl.2019.02.028_b0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.cellbio.23.090506.123555","article-title":"Two families of chaperonin: physiology and mechanism","volume":"23","author":"Horwich","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0070","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jmb.2012.11.028","article-title":"Structure and allostery of the chaperonin GroEL","volume":"425","author":"Saibil","year":"2013","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0075","doi-asserted-by":"crossref","first-page":"15800","DOI":"10.1073\/pnas.0607534103","article-title":"Global aggregation of newly translated proteins in an Escherichia coli strain deficient of the chaperonin GroEL","volume":"103","author":"Chapman","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2019.02.028_b0080","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/jb.171.3.1379-1385.1989","article-title":"The groES and groEL heat shock gene products of Escherichia coli are essential for bacterial growth at all temperatures","volume":"171","author":"Fayet","year":"1989","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2008.10.011","article-title":"Molecular chaperones in pathogen virulence: emerging new targets for therapy","volume":"4","author":"Neckers","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bmcl.2019.02.028_b0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1101\/gr.115089.110","article-title":"High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome","volume":"21","author":"Alsford","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.bmcl.2019.02.028_b0095","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2005.09.012","article-title":"GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria","volume":"123","author":"Ojha","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2019.02.028_b0100","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/IAI.01078-07","article-title":"Mycobacterium tuberculosis mutant lacking the groEL homologue cpn60.1 is viable but fails to induce an inflammatory response in animal models of infection","volume":"76","author":"Hu","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.bmcl.2019.02.028_b0105","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1093\/nar\/gkq618","article-title":"The Trypanosoma brucei MitoCarta and its regulation and splicing pattern during development","volume":"38","author":"Zhang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2019.02.028_b0110","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1073\/pnas.90.7.2608","article-title":"Mycobacterium-tuberculosis expresses 2 chaperonin-60 homologs","volume":"90","author":"Kong","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"44","key":"10.1016\/j.bmcl.2019.02.028_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2911(01)44012-4","article-title":"Microbial molecular chaperones","volume":"44","author":"Lund","year":"2001","journal-title":"Adv Microb Physiol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12192-015-0598-8","article-title":"Multiple chaperonins in bacteria-novel functions and non-canonical behaviors","volume":"20","author":"Kumar","year":"2015","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.bmcl.2019.02.028_b0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1574-6968.2010.02039.x","article-title":"Differential expression of the multiple chaperonins of Mycobacterium smegmatis","volume":"310","author":"Rao","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.bmcl.2019.02.028_b0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1574-6976.2007.00069.x","article-title":"A postgenomic view of the heat shock proteins in kinetoplastids","volume":"31","author":"Folgueira","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmcl.2019.02.028_b0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0166-6851(95)02486-7","article-title":"Molecular characterization of the mitochondrial heat shock protein 60 gene from Trypanosoma brucei","volume":"74","author":"Bringaud","year":"1995","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0140","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/IAI.68.2.848-860.2000","article-title":"Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei","volume":"68","author":"Radwanska","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.bmcl.2019.02.028_b0145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-3024.2000.00348.x","article-title":"Antibodies raised against the flagellar pocket fraction of Trypanosoma brucei preferentially recognize HSP60 in cDNA expression library","volume":"22","author":"Radwanska","year":"2000","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/1574-6968.12276","article-title":"Mycobacterial chaperonins: the tail wags the dog","volume":"350","author":"Colaco","year":"2014","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.bmcl.2019.02.028_b0155","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1110\/ps.9.3.476","article-title":"Conservation among HSP60 sequences in relation to structure, function, and evolution","volume":"9","author":"Brocchieri","year":"2000","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmcl.2019.02.028_b0160","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.bmcl.2016.04.089","article-title":"GroEL\/ES inhibitors as potential antibiotics","volume":"26","author":"Abdeen","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.02.028_b0165","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1016\/j.bmcl.2016.09.051","article-title":"Targeting the HSP60\/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness","volume":"26","author":"Abdeen","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.02.028_b0170","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1021\/acs.jmedchem.8b00989","article-title":"Sulfonamido-2-arylbenzoxazole GroEL\/ES inhibitors as Potent antibacterials against methicillin-resistant staphylococcus aureus (MRSA)","volume":"61","author":"Abdeen","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.028_b0175","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b01293","article-title":"Hydroxybiphenylamide GroEL\/ES inhibitors are potent antibacterials against planktonic and biofilm forms of staphylococcus aureus","author":"Kunkle","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.028_b0180","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bmcl.2013.12.100","article-title":"A biochemical screen for GroEL\/GroES inhibitors","volume":"24","author":"Johnson","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.02.028_b0185","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2019.02.028_b0190","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2307\/3281582","article-title":"The efficacy of closantel against Fascioloides magna in sheep","volume":"70","author":"Stromberg","year":"1984","journal-title":"J Parasitol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fmolb.2018.00035","article-title":"Toward developing chemical modulators of Hsp60 as potential therapeutics","volume":"5","author":"Meng","year":"2018","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.bmcl.2019.02.028_b0200","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1016\/j.bmcl.2004.06.054","article-title":"Structure-activity relationships of epolactaene derivatives: structural requirements for inhibition of Hsp60 chaperone activity","volume":"14","author":"Nagumo","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.02.028_b0205","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/BJ20041355","article-title":"Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity","volume":"387","author":"Nagumo","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2019.02.028_b0210","doi-asserted-by":"crossref","first-page":"614-+","DOI":"10.1016\/j.chembiol.2017.04.008","article-title":"Mitochondrial chaperonin HSP60 is the apoptosis-related target for myrtucommulone","volume":"24","author":"Wiechmann","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0215","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0220","doi-asserted-by":"crossref","first-page":"12281","DOI":"10.1074\/jbc.273.20.12281","article-title":"Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases","volume":"273","author":"Zhang","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.02.028_b0225","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1432-1033.1996.0592h.x","article-title":"6-Phosphogluconate dehydrogenase from Trypanosoma brucei. Kinetic analysis and inhibition by trypanocidal drugs","volume":"240","author":"Hanau","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmcl.2019.02.028_b0230","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0166-6851(80)90050-X","article-title":"Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo","volume":"1","author":"Fairlamb","year":"1980","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0235","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0163-7258(93)90016-7","article-title":"Inhibition of the glycolytic enzymes in the trypanosome: an approach in the development of new leads in the therapy of parasitic diseases","volume":"60","author":"Perie","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2019.02.028_b0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0166-6851(93)90218-M","article-title":"Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei","volume":"59","author":"Willson","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmcl.2019.02.028_b0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.pa.35.040195.000521","article-title":"Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis","volume":"35","author":"Wang","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1930112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1930112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:28:11Z","timestamp":1760772491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X1930112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0960894X1930112X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.02.028","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HSP60\/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}